(Q42783336)

7 November 2017

Relationship between labile plasma iron, liver iron concentration and cardiac response in a deferasirox monotherapy trial (English)

1 reference

7 November 2017

4

Patricia Giardina

1 reference

7 November 2017

John C Wood

1

1 reference

7 November 2017

Tara Glynos

2

1 reference

7 November 2017

Alexis Thompson

3

1 reference

7 November 2017

Paul Harmatz

5

1 reference

7 November 2017

Barinder P Kang

6

1 reference

7 November 2017

Carole Paley

7

1 reference

7 November 2017

Thomas D Coates

8

1 reference

7 November 2017

10 March 2011

1 reference

7 November 2017

1 reference

7 November 2017

96

1 reference

7 November 2017

7

1 reference

7 November 2017

1055-1058

1 reference

Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemia

7 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128226

Longitudinal analysis of heart and liver iron in thalassemia major

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128226

Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128226

LPI-labile plasma iron in iron overload

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128226

Hepatic iron concentration and total body iron stores in thalassemia major.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128226

Results of long-term iron-chelating therapy

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128226

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128226

The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128226

Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128226

Daily labile plasma iron as an indicator of chelator activity in Thalassaemia major patients

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128226

Development of thalassaemic iron overload cardiomyopathy despite low liver iron levels and meticulous compliance to desferrioxamine.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128226

Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128226

Labile plasma iron in iron overload: redox activity and susceptibility to chelation

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128226

Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128226

Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128226

Survival in medically treated patients with homozygous beta-thalassemia

16 August 2018

1 reference

12 December 2020

High nontransferrin bound iron levels and heart disease in thalassemia major

1 reference

12 December 2020

Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients

1 reference

12 December 2020

Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major

1 reference

12 December 2020

10.3324/HAEMATOL.2010.032862

Identifiers

DOI

1 reference

release_jtb7naosgrhsnljh77qyhgyete

7 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jtb7naosgrhsnljh77qyhgyete

24 November 2022

mapped directly with Wikidata item

1 reference

7 November 2017

PubMed publication ID

21393329

1 reference